Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing.

Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing.

Frontiers in Genetics (2023)

Hu, et al.

材料

产品编号

品牌

产品描述

Sigma-Aldrich

胎儿蛋白（AFP）单克隆抗体小鼠抗, ascites fluid, clone C3

Sigma-Aldrich

抗HNF3β/FOXA2抗体, Upstate^®, from rabbit